The University of North Carolina at Chapel Hill has been awarded $2.5 million from the National Institutes of Health to establish a new cooperative research center for studies of sexually transmitted infections (STIs).
In a review article published this month in The Oncologist, UNC’s Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases for existing drugs.
The John B. Graham Medical Student Research Society hosts 42nd Annual Student Research Day on Wednesday, Jan. 27, 2010. The day will kick off with a keynote address by Dr. Edward Benz, President and CEO of the Dana Farber Cancer Center. Student research presentations will follow.